Farallon Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | – | Sell |
-77,531
| Closed | -$4.45M | – | 100 |
|
|
2014
Q2 | $4.45M | Buy |
77,531
+37,200
| +92% | +$2.13M | 0.06% | 72 |
|
|
2014
Q1 | $1.6M | Sell |
40,331
-62,025
| -61% | -$2.46M | 0.03% | 77 |
|
|
2013
Q4 | $4.3M | Hold |
102,356
| – | – | 0.09% | 66 |
|
|
2013
Q3 | $3.06M | Sell |
102,356
-33,328
| -25% | -$996K | 0.06% | 71 |
|
|
2013
Q2 | $7.19M | Buy |
+135,684
| New | +$7.19M | 0.14% | 58 |
|